1. Home
  2. OFLX vs HELP Comparison

OFLX vs HELP Comparison

Compare OFLX & HELP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Omega Flex Inc.

OFLX

Omega Flex Inc.

HOLD

Current Price

$31.22

Market Cap

299.4M

Sector

Industrials

ML Signal

HOLD

HELP

Cybin Inc. Common Stock

N/A

Current Price

$4.02

Market Cap

279.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OFLX
HELP
Founded
1975
N/A
Country
United States
Canada
Employees
N/A
50
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
299.4M
279.9M
IPO Year
2005
N/A

Fundamental Metrics

Financial Performance
Metric
OFLX
HELP
Price
$31.22
$4.02
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$51.50
AVG Volume (30 Days)
34.3K
610.6K
Earning Date
04-29-2026
07-01-2026
Dividend Yield
4.05%
N/A
EPS Growth
N/A
N/A
EPS
0.21
N/A
Revenue
$98,296,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$148.48
N/A
Revenue Growth
N/A
N/A
52 Week Low
$25.58
$3.76
52 Week High
$37.92
$8.55

Technical Indicators

Market Signals
Indicator
OFLX
HELP
Relative Strength Index (RSI) 57.63 36.62
Support Level $26.51 N/A
Resistance Level $31.47 $4.75
Average True Range (ATR) 1.05 0.26
MACD 0.29 -0.04
Stochastic Oscillator 86.75 24.29

Price Performance

Historical Comparison
OFLX
HELP

About OFLX Omega Flex Inc.

Omega Flex Inc is a manufacturer of flexible metal hoses, which is used in a variety of ways to carry gases and liquids within their particular applications. Omega sells its products under the TracPipe, CounterStrike, DoubleTrac, DEF-Trac and MediTrac brands. It serves various markets which include construction, manufacturing, transportation, petrochemical, pharmaceutical, and other industries. Geographically Omega Flex, Inc operates in the United States. The company derives revenues from the manufacture and sale of flexible metal hose and accessories.

About HELP Cybin Inc. Common Stock

Helus Pharma Inc, the commercial operating name of Cybin Inc, is a clinical-stage pharmaceutical company focused on developing proprietary neuroactive compounds, referred to as NSAs, which are synthetic molecules designed to target serotonin pathways. The company's programs are aimed at treating mental health conditions such as depression and anxiety. Its pipeline includes HLP003, which is in clinical development for the adjunctive treatment of depressive disorder, and HLP004, which is in clinical development for generalized anxiety disorder. The company also conducts research on additional investigational compounds.

Share on Social Networks: